Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Income towards Parent Company (2020 - 2025)

Historic Income towards Parent Company for Medicale (MCLE) over the last 4 years, with Q3 2025 value amounting to -$8654.0.

  • Medicale's Income towards Parent Company changed N/A to -$8654.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$18657.0, marking a year-over-year change of. This contributed to the annual value of -$33652.0 for FY2025, which is N/A changed from last year.
  • Latest data reveals that Medicale reported Income towards Parent Company of -$8654.0 as of Q3 2025.
  • Medicale's 5-year Income towards Parent Company high stood at $455.0 for Q4 2022, and its period low was -$8654.0 during Q3 2025.
  • Moreover, its 3-year median value for Income towards Parent Company was -$3575.0 (2025), whereas its average is -$3749.1.
  • Over the last 5 years, Medicale's Income towards Parent Company had its largest YoY gain of 17583.33% in 2022, and its largest YoY loss of 9083.55% in 2022.
  • Medicale's Income towards Parent Company (Quarter) stood at -$600.0 in 2021, then skyrocketed by 175.83% to $455.0 in 2022, then crashed by 2001.98% to -$8654.0 in 2025.
  • Its Income towards Parent Company stands at -$8654.0 for Q3 2025, versus -$3575.0 for Q2 2025 and -$6428.0 for Q1 2025.